The present study in vivo further confirmed the role of p38 MAPK activation in the above process using a rats’ global cerebral ischemia model, which might be particularly valuable for the establishment of the conclusion that p38 MAPK activation participates in the sulbactam-induced neuronal protection against ischemic insult via GLT-1 upregulation. Here, SLC1A2 is linked to brain ischemia.